Separately, The Compound Is Being Tested In Human Clinical Trials In Rheumatoid Arthritis, Which Is Also Promising, Sharma Said.

Archives of Ophthalmology. 2010;128:738. Do not lift any heavy objects. With cataract surgery, your eye’s cloudy natural lens is removed and replaced with a clear artificial lens implant called an intra ocular lens or IOU. After the cataract is removed, the surgeon usually replaces it with a new, man-made lens called an intra ocular lens or IOU. What is a cataract and how is it treated? Another step you can take to reduce your risk of cataracts is to wear protective sunglasses that block 100 percent of the sun’s UV rays when you are outdoors. The Top Information On Choosing Critical Criteria Of Eye Bags | Suggestions For The EyeballsMares A, et al. Scientists Working on Eye Drops to Dissolve Cataracts August 2015 — Cataract surgery is proven to be safe and effective, with a low risk of serious complications.

After battling diabetes for nearly 40 years, Lowe has developed diabetic retinopathy, a consequence of uncontrolled diabetes that can damage small blood vessels in the eye and is the leading cause of blindness among working-age adults. A researcher across campus from the clinic is looking at a different way of potentially blocking the inflammation that can lead to that damage through a potential new drug. Dr. Shruti Sharma of the Center for Biotechnology and Genomic Medicine has a $1.5 million grant from the National Eye Institute to look at basic research into blocking inflammation among epithelial cells in light-sensing retina in the eye, Sharma is looking at a well-known agent in inflammation called interleukin-6 that can affect those cells even though they lack the receptor normally needed for such interaction, an effect called trans-signaling. While that effect had been known for a while it is not something that researchers had focused on in the past, she said. Sharma is looking at an experimental drug that in her early work seems to have blocked that type of action in those cells, using it both in the lab in human cells in the same kind of environment that is there in the eye and in a mouse model of diabetes. The hope is to prevent the barrier disruption to the cells that can cause them to become leaky and create inflammation, an early hallmark of the disease. Almost All People With Diabetes Show Signs Of Retinal Damage After About 20 Years Of Living With The Condition. | Good Christian SimmonsThe mouse model allows Sharma to test the compound in both late and early stages of the disease to see if it she can prevent diabetic retinopathy from happening, she said. Separately, the compound is being tested in human clinical trials in rheumatoid arthritis, which is also promising, Sharma said. Im more excited because I am re-purposing this drug, she said.

For the original version including any supplementary images or video, visit http://www.washingtontimes.com/news/2017/jan/1/new-drug-might-help-with-diabetes-related-blindnes/?utm_source=RSS_Feed&utm_medium=RSS

Leave a Reply

Your email address will not be published. Required fields are marked *